Skip to content
DataLookout
Menu

RECORDIINCT07739316

Systematic Ambulatory ECG Monitoring Following TAVI

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened Show 4 more changesShow less
    • Eligibility criteria expanded, about 8 words
    • Start date changed from estimate of Aug 2026 to Oct 23, 2026
    • Site details revised
    • Publications: details revised at 28 of 28 entries
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Rate of the combined endpoint (sudden death, symptomatic arrhythmias or stroke)
Timeframe: Within the year following the TAVI procedure

Secondary (21)

Incidence of sudden death
Incidence of symptomatic arrhythmias
Incidence of stroke
Incidence of PPI
Incidence of the combined endpoint (sudden death, symptomatic arrhythmias or stroke) at 30 days
Show 16 moreShow less
Incidence of symptomatic arrhytmias
Incidence of the combined endpoint (sudden death, symptomatic arrhythmias, stroke) according to patient sex
Incidence of the combined endpoint of sudden death, symptomatic arrhythmias, or stroke) according to ECG abnormalities
Incidence of the combined endpoint according to baseline ECG abnormality type
Incidence of sudden death according to baseline ECG abnormality type
Incidence of symptomatic arrhythmias according to baseline ECG abnormality type
Incidence of stroke according to baseline ECG abnormality type
Incidence of the combined endpoint according to discharge ECG abnormality type
Incidence of sudden death according to discharge ECG abnormality type
Incidence of symptomatic arrhythmias according to discharge ECG abnormality type
Incidence of stroke according to discharge ECG abnormality type
Change in quality of life
Percentage of ventricular pacing
Incidence of all-cause mortality
Incidence of cardiovascular mortality
Incidence of cardiovasculare mortality

Arms and interventions

Ambulatory ECG monitoringExperimental

Participants will undergo ambulatory ECG monitoring at hospital discharge following TAVI. Continuous ECG monitoring will be performed for 14 days using an ambulatory ECG monitoring device. Clinically significant bradyarrhythmias or tachyarrhythmias detected during monitoring will be reviewed and managed according to clinical practice, including appropriate therapeutic interventions when indicated.

Standard care (no ambulatory ECG monitoring device).No intervention

Participants will receive standard post-TAVI care without systematic ambulatory ECG monitoring at hospital discharge. Clinical follow-up will be performed according to routine practice.

Devices: Ambulatory ECG monitoring

Sites

1 site in 1 country

  • Institut universitaire de cardiologie et de pneumologie de Québec - ULQuébec, Quebec, Canada